The American Cancer Society (ACS) has estimated that 224,390 new cases of lung cancer will be diagnosed in the United States in 2016 with an estimated 158,080 deaths expected. Lung cancer is the second most commonly diagnosed cancer and is the leading cause of cancer death.
This information was originally presented at the NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, from March 23 - 25, 2017.
This information was originally presented at the NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, from March 23 - 25, 2017.
This information was originally presented at the NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, from March 23 - 25, 2017.
This information was originally presented at the NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, from March 23 - 25, 2017.
Join Karen L. Reckamp, MD and Carrie Christiansen, RN, MSN, CFNP from City of Hope Comprehensive Cancer Center as they present their expertise on a range of cases pertaining to lung cancer.
Join Karen L. Reckamp, MD and Carrie Christiansen, RN, MSN, CFNP from City of Hope Comprehensive Cancer Center as they present their expertise on a range of cases pertaining to lung cancer.
Immunotherapy is emerging as a novel modality for controlling cancer and has been proposed as becoming the fourth cornerstone of cancer treatment along with surgery, radiotherapy, and chemotherapy.
Immunotherapy is emerging as a novel modality for controlling cancer and has been proposed as becoming the fourth cornerstone of cancer treatment along with surgery, radiotherapy, and chemotherapy.
Immunotherapy is emerging as a novel modality for controlling cancer and has been proposed as becoming the fourth cornerstone of cancer treatment along with surgery, radiotherapy, and chemotherapy.